Pfizer Launches Expanded Access Program For CCR5 Antagonist Maraviroc

Pfizer will begin enrolling HIV patients in the next “few months” and will recruit investigators that have not previously worked in expanded access.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet